fContribution of CXCL12 secretion to invasion of breast cancer cells

Breast Cancer Research

Volumn 14, Issue 1, 2012, Pages

  Boimel, Pamela J ^a   Smirnova, Tatiana ^a   Zhou, Zhen N ^a   Wyckoff, Jeffrey ^a   Park, Haein ^a   Coniglio, Salvatore J ^a   Qian, Bin Zhi ^a   Stanley, E Richard ^a   Cox, Dianne ^a   Pollard, Jeffrey W ^a   Muller, William J ^b   Condeelis, John ^a   Segall, Jeffrey E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DECTIN 1; PLERIXAFOR; CXCL12 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, MOUSE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELETION MUTANT; FEMALE; GENE OVEREXPRESSION; MACROPHAGE; METASTASIS; MICROVASCULATURE; MOUSE; MOUSE STRAIN; MULTIPHOTON MICROSCOPY; NEU NDL STRAIN; NEU YB STRAIN; NEU YD STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; TUMOR MICROENVIRONMENT; TUMOR VOLUME; WOUND HEALING; ADENOCARCINOMA; ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; EXPERIMENTAL NEOPLASM; GENETICS; HUMAN; LUNG TUMOR; MACROPHAGE ACTIVATION; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); TUMOR CELL CULTURE; TUMOR EMBOLISM; VASCULARIZATION; VIDEO MICROSCOPY;

ADENOCARCINOMA; ANIMALS; CELL MOVEMENT; CHEMOKINE CXCL12; FEMALE; HUMANS; LUNG NEOPLASMS; MACROPHAGE ACTIVATION; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICROSCOPY, VIDEO; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASTIC CELLS, CIRCULATING; PARACRINE COMMUNICATION; RATS; RECEPTOR, ERBB-2; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; TUMOR BURDEN; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84862777272     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3108     Document Type: Article

References (53)

1. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244:707-712. 10.1126/science.2470152, 2470152.
2. Yarden Y. The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. Eur J Cancer 2001, 37(Suppl 4):S3-S8.
3. Klapper LN, Glathe S, Vaisman N, Hynes NE, Andrews GC, Sela M, Yarden Y. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proc Natl Acad Sci USA 1999, 96:4995-5000. 10.1073/pnas.96.9.4995, 21805, 10220407.
4. Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ, Yarden Y. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol 1996, 16:5276-5287. 231527, 8816440.
5. Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin BJ, Sela M, Yarden Y. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J 1996, 15:2452-2467. 450177, 8665853.
6. Ghosh R, Narasanna A, Wang SE, Liu S, Chakrabarty A, Balko JM, González-Angulo AM, Mills GB, Penuel E, Winslow J, Sperinde J, Dua R, Pidaparthi S, Mukherjee A, Leitzel K, Kostler WJ, Lipton A, Bates M, Arteaga CL. Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers. Cancer Res 2011, 71:1871-1882. 10.1158/0008-5472.CAN-10-1872, 3221734, 21324925.
7. Landgraf R. HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks. Breast Cancer Res 2007, 9:202. 10.1186/bcr1633, 1851388, 17274834.
8. Hudis CA. Trastuzumab: mechanism of action and use in clinical practice. N Engl J Med 2007, 357:39-51. 10.1056/NEJMra043186, 17611206.
9. Nahta R, Esteva FJ. HER2 therapy: molecular mechanisms of trastuzumab resistance. Breast Cancer Res 2006, 8:215. 10.1186/bcr1612, 1797036, 17096862.
10. Siegel PM, Ryan ED, Cardiff RD, Muller WJ. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J 1999, 18:2149-2164. 10.1093/emboj/18.8.2149, 1171299, 10205169.
11. Siegel PM, Dankort DL, Hardy WR, Muller WJ. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol 1994, 14:7068-7077. 359240, 7935422.
12. Dankort DL, Wang Z, Blackmore V, Moran MF, Muller WJ. Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation. Mol Cell Biol 1997, 17:5410-5425. 232391, 9271418.
13. Dankort DL, Muller WJ. Signal transduction in mammary tumorigenesis: a transgenic perspective. Oncogene 2000, 19:1038-1044. 10.1038/sj.onc.1203272, 10713687.
14. Schade B, Lam SH, Cernea D, Sanguin-Gendreau V, Cardiff RD, Jung BL, Hallett M, Muller WJ. Distinct ErbB-2 coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles. Cancer Res 2007, 67:7579-7588. 10.1158/0008-5472.CAN-06-4724, 17699761.
15. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-572. 10.1038/nrc865, 12154349.
16. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56. 10.1038/35065016, 11242036.
17. Salvucci O, Bouchard A, Baccarelli A, Deschenes J, Sauter G, Simon R, Bianchi R, Basik M. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat 2006, 97:275-283. 10.1007/s10549-005-9121-8, 16344916.
18. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348. 10.1016/j.cell.2005.02.034, 15882617.
19. Fernandis AZ, Prasad A, Band H, Klösel R, Ganju RK. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 2004, 23:157-167. 10.1038/sj.onc.1206910, 14712221.
20. Lee BC, Lee TH, Avraham S, Avraham HK. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1α in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2004, 2:327-338.
21. Kishimoto H, Wang Z, Bhat-Nakshatri P, Chang D, Clarke R, Nakshatri H. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1α/CXCL12. Carcinogenesis 2005, 26:1706-1715. 10.1093/carcin/bgi137, 15917309.
22. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007, 28:299-307. 10.1016/j.it.2007.05.007, 2952492, 17560169.
23. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 2007, 292:C987-C995.
24. Sánchez-Martín L, Estecha A, Samaniego R, Sánchez-Ramón S, Vega M, Sánchez-Mateos P. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood 2011, 117:88-97. 10.1182/blood-2009-12-258186, 20930067.
25. Kang H, Watkins G, Parr C, Douglas-Jones A, Mansel RE, Jiang WG. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res 2005, 7:R402-R410. 10.1186/bcr1022, 1175055, 15987445.
26. Epstein RJ. The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies. Nat Rev Cancer 2004, 4:901-909. 10.1038/nrc1473, 15516962.
27. Duda DG, Kozin SV, Kirkpatrick ND, Xu L, Fukumura D, Jain RK. CXCL12 (SDF1α)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?. Clin Cancer Res 2011, 17:2074-2080. 10.1158/1078-0432.CCR-10-2636, 21349998.
28. Entenberg D, Wyckoff J, Gligorijevic B, Roussos ET, Verkhusha VV, Pollard JW, Condeelis J. Setup and use of a two-laser multiphoton microscope for multichannel intravital fluorescence imaging. Nat Protoc 2011, 6:1500-1520. 10.1038/nprot.2011.376, 21959234.
29. Wyckoff J, Gligorijevic B, Entenberg D, Segall J, Condeelis J. High-resolution multiphoton imaging of tumors in vivo. Live Cell Imaging: A Laboratory Manual 2010, 441-462. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, Goldman RD, Swedlow JR, Spector DL, 2.
30. Neri A, Welch D, Kawaguchi T, Nicolson GL. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 1982, 68:507-517.
31. Hernandez L, Magalhaes MA, Coniglio SJ, Condeelis JS, Segall JE. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis. Breast Cancer Res 2011, 13:R128. 10.1186/bcr3074, 22152016.
32. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative: a new fixation for immunoelectron microscopy. J Histochem Cytochem 1974, 22:1077-1083. 10.1177/22.12.1077, 4374474.
33. Gouon-Evans V, Lin EY, Pollard JW. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res 2002, 4:155-164. 10.1186/bcr441, 138736, 12100741.
34. Hernandez L, Smirnova T, Wyckoff J, Condeelis J, Segall JE. In vivo assay for tumor cell invasion. Methods Mol Biol 2009, 571:227-238. 10.1007/978-1-60761-198-1_15, 3156574, 19763970.
35. Sudo T, Nishikawa S, Ogawa M, Kataoka H, Ohno N, Izawa A, Hayashi S. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 1995, 11:2469-2476.
36. Gebäck T, Schulz MM, Koumoutsakos P, Detmar M. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 2009, 46:265-274.
37. Stanley ER. Murine bone marrow-derived macrophages. Methods Mol Biol 1997, 75:301-304.
38. Xue C, Liang F, Mahmood R, Vuolo M, Wyckoff J, Qian H, Tsai KL, Kim M, Locker J, Zhang ZY, Segall JE. ErbB3-dependent motility and intravasation in breast cancer metastasis. Cancer Res 2006, 66:1418-1426. 10.1158/0008-5472.CAN-05-0550, 16452197.
39. Dankort D, Maslikowski B, Warner N, Kanno N, Kim H, Wang Z, Moran MF, Oshima RG, Cardiff RD, Muller WJ. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol Cell Biol 2001, 21:1540-1551. 10.1128/MCB.21.5.1540-1551.2001, 86700, 11238891.
40. Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, Stanley ER, Segall JE, Condeelis JS. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005, 65:5278-5283. 10.1158/0008-5472.CAN-04-1853, 15958574.
41. Hernandez L, Smirnova T, Kedrin D, Wyckoff J, Zhu L, Stanley ER, Cox D, Muller WJ, Pollard JW, Van Rooijen N, Segall JE. The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin β1 and CXCL12. Cancer Res 2009, 69:3221-3227. 10.1158/0008-5472.CAN-08-2871, 2820720, 19293185.
42. Porta C, Subhra Kumar B, Larghi P, Rubino L, Mancino A, Sica A. Tumor promotion by tumor-associated macrophages. Adv Exp Med Biol 2007, 604:67-86. 10.1007/978-0-387-69116-9_5, 17695721.
43. Porcile C, Bajetto A, Barbieri F, Barbero S, Bonavia R, Biglieri M, Pirani P, Florio T, Schettini G. Stromal cell-derived factor-1α (SDF-1α/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp Cell Res 2005, 308:241-253. 10.1016/j.yexcr.2005.04.024, 15921680.
44. Hagemann T, Robinson SC, Schulz M, Trümper L, Balkwill FR, Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004, 25:1543-1549. 10.1093/carcin/bgh146, 15044327.
45. Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, Segall JE, Pollard JW, Condeelis J. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007, 67:2649-2656. 10.1158/0008-5472.CAN-06-1823, 17363585.
46. Rigo A, Gottardi M, Zamo A, Mauri P, Bonifacio M, Krampera M, Damiani E, Pizzolo G, Vinante F. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. Mol Cancer 2010, 9:273. 10.1186/1476-4598-9-273, 2964621, 20946648.
47. Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, Elliott S, Wei Y, Yu D, Sun M, Muir SE, Fonseca JP, Bratton MR, Segar C, Tilghman SL, Sobolik-Delmaire T, Horton LW, Zaja-Milatovic S, Collins-Burow BM, Wadsworth S, Beckman BS, Wood CE, Fuqua SA, Nephew KP, Dent P, Worthylake RA, Curiel TJ, Hung MC, Richmond A, Burow ME. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res 2011, 71:603-613. 10.1158/0008-5472.CAN-10-3185, 3140407, 21123450.
48. Cabioglu N, Summy J, Miller C, Parikh NU, Sahin AA, Tuzlali S, Pumiglia K, Gallick GE, Price JE. CXCL-12/stromal cell-derived factor-1α transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res 2005, 65:6493-6497. 10.1158/0008-5472.CAN-04-1303, 16061624.
49. Mosadegh B, Saadi W, Wang SJ, Jeon NL. Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients. Biotechnol Bioeng 2008, 100:1205-1213. 10.1002/bit.21851, 18553401.
50. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51. 10.1016/j.cell.2010.03.014, 20371344.
51. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006, 66:11238-11246. 10.1158/0008-5472.CAN-06-1278, 17114237.
52. Lazennec G, Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 2010, 16:133-144. 10.1016/j.molmed.2010.01.003, 2840699, 20163989.
53. Lewis JS, Landers RJ, Underwood JC, Harris AL, Lewis CE. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 2000, 192:150-158. 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G, 11004690.